Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swapnil Rajurkar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|July 10, 2020
The Community Oncology and Academic Medical Center Alliance in the Age of Precision Medicine: Cancer Genetics and Genomics ConsiderationsMarilena Melas, Shanmuga Subbiah, Siamak Saadat, et al.
Cancer Treatment and Research|August 23, 2025
Immunotherapy in MelanomaYan Xing, Helena T Wu, Swapnil Rajurkar, et al.
Medicine|November 12, 2020
Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case reportJeremy Fricke, Isa Mambetsariev, Rebecca Pharaon, et al.
Journal of Clinical Medicine|June 19, 2020
Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy StrategiesSwapnil Rajurkar, Isa Mambetsariev, Rebecca Pharaon, et al.
Journal of Clinical Medicine|November 26, 2022
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care PlansLinda D Bosserman, Isa Mambetsariev, Colton Ladbury, et al.
Journal of Clinical Medicine|January 21, 2023
A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung CancerSravani Ramisetty, Prakash Kulkarni, Supriyo Bhattacharya, et al.
Cancers|September 9, 2022
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast CancerXuan Ge, Susan E Yost, Jin Sun Lee, et al.
Cancer Research|August 7, 2012
The microculture-kinetic (MiCK) assay: the role of a drug-induced apoptosis assay in drug development and clinical careLinda Bosserman, Franklyn Prendergast, Roy Herbst, et al.
Journal of Clinical Medicine|October 14, 2022
Addressing Drug Resistance in Cancer: A Team Medicine ApproachPrakash Kulkarni, Atish Mohanty, Supriyo Bhattacharya, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|July 10, 2020
The Community Oncology and Academic Medical Center Alliance in the Age of Precision Medicine: Cancer Genetics and Genomics ConsiderationsMarilena Melas, Shanmuga Subbiah, Siamak Saadat, et al.
Cancer Treatment and Research|August 23, 2025
Immunotherapy in MelanomaYan Xing, Helena T Wu, Swapnil Rajurkar, et al.
Medicine|November 12, 2020
Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case reportJeremy Fricke, Isa Mambetsariev, Rebecca Pharaon, et al.
Journal of Clinical Medicine|June 19, 2020
Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy StrategiesSwapnil Rajurkar, Isa Mambetsariev, Rebecca Pharaon, et al.
Journal of Clinical Medicine|November 26, 2022
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care PlansLinda D Bosserman, Isa Mambetsariev, Colton Ladbury, et al.
Journal of Clinical Medicine|January 21, 2023
A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung CancerSravani Ramisetty, Prakash Kulkarni, Supriyo Bhattacharya, et al.
Cancers|September 9, 2022
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast CancerXuan Ge, Susan E Yost, Jin Sun Lee, et al.
Cancer Research|August 7, 2012
The microculture-kinetic (MiCK) assay: the role of a drug-induced apoptosis assay in drug development and clinical careLinda Bosserman, Franklyn Prendergast, Roy Herbst, et al.
Journal of Clinical Medicine|October 14, 2022
Addressing Drug Resistance in Cancer: A Team Medicine ApproachPrakash Kulkarni, Atish Mohanty, Supriyo Bhattacharya, et al.
Pageof 1